| Positive Results from Phase 2 Study of Atrasentan for Treatment of Diabetic ... - PR Newswire (press release) |
|
|
PR Newswire (press release) ABBOTT PARK, Ill., March 4, 2011 /PRNewswire/ -- Results from a Phase 2, 8-week dose-ranging study using low doses of atrasentan in patients with diabetic kidney disease were published this week in the Journal of the American Society of Nephrology. |